Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc. (UBER), Comcast ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Buy GILD near 92.28 target 99.72 stop loss @ 92.01 Details The technical summary data tells us to buy GILD near 92.28 with an upside target of 99.72. This data also tells us to set a stop loss @ 92.01 ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

Buy GILD near 88.49 target 97.33 stop loss @ 88.23 Details The technical summary data tells us to buy GILD near 88.49 with an upside target of 97.33. This data also tells us to set a stop loss @ 88.23 ...

Lenacapavir, the first and only twice-yearly injectable treatment for HIV, has shown exceptional efficacy and safety in clinical trials. Gilead Sciences, Inc. (NASDAQ:GILD) plans to launch ...

Presuming that FDA approval will arrive as expected in November, Gilead will still face some potentially major obstacles and uncertainties. First of all is the pricing of axi-cel: some analysts ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...